SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (103)12/6/2002 11:21:57 AM
From: Jibacoa  Respond to of 3722
 
VPHM Is up 23% on volume of 123K.

The question for today is wether it will be able to close above its December 2 H of 1.70

The stock had a good short run from its November 1 close of 0.93 to its November 7 intra-day H of 1.74 (87% gain on 4 trading days.<g>)

The November 7 H was above the July 7 H of 1.75, but the stock is still far from being able to close its May 10 down-gap above 3.50.(The March 19-March 20 down-gap from 13.42 to 7.01 is not yet worth mentioning.<g>)

VPHM had a somewhat complicated 3rd Q report, because of its deals with AVE.(Sold the workforce for more than 15M,purchased $23M of its convertible notes for $8.2M for a gain of $15.2M and AVE bought about 4M of VPHM stock and R&D expenses were more than $3M less than in 2001.)

As of September 30 VPHM still had around $176 M in cash. (About $6.79/share)<g>)Insiders hold 50% and reportedly had done some buying lately.

bigcharts.marketwatch.com

bigcharts.marketwatch.com

Bernard